25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GIKLY (Grifols) Stock Analysis
Buy, Hold or Sell?

Let's analyze Grifols together

I guess you are interested in Grifols SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Grifols’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Grifols’s Price Targets

I'm going to help you getting a better view of Grifols SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.

1. Quick Overview

1.1. Quick analysis of Grifols (30 sec.)










1.2. What can you expect buying and holding a share of Grifols? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
$7.02
Expected worth in 1 year
$3.54
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
$-3.48
Return On Investment
-74.8%

For what price can you sell your share?

Current Price per Share
$4.65
Expected price per share
$3.762 - $4.8
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Grifols (5 min.)




Live pricePrice per Share (EOD)
$4.65
Intrinsic Value Per Share
$2.95 - $13.72
Total Value Per Share
$9.97 - $20.74

2.2. Growth of Grifols (5 min.)




Is Grifols growing?

Current yearPrevious yearGrowGrow %
How rich?$9.5b$9.1b$18.1m0.2%

How much money is Grifols making?

Current yearPrevious yearGrowGrow %
Making money$43.5m$45.7m-$2.2m-5.1%
Net Profit Margin2.1%2.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Grifols (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Grifols?

Welcome investor! Grifols's management wants to use your money to grow the business. In return you get a share of Grifols.

First you should know what it really means to hold a share of Grifols. And how you can make/lose money.

Speculation

The Price per Share of Grifols is $4.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Grifols.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Grifols, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $7.02. Based on the TTM, the Book Value Change Per Share is $-0.87 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Grifols.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.061.2%0.040.9%0.051.2%0.051.1%0.061.3%0.091.9%
Usd Book Value Change Per Share-3.49-75.0%-0.87-18.7%-0.06-1.3%-0.22-4.7%0.081.6%0.122.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.040.8%0.061.2%
Usd Total Gains Per Share-3.49-75.0%-0.87-18.7%-0.06-1.3%-0.22-4.7%0.112.4%0.183.8%
Usd Price Per Share4.70-4.61-6.61-6.13-9.20-10.54-
Price to Earnings Ratio20.89-33.35--4.96-20.46-21.20-23.31-
Price-to-Total Gains Ratio-1.35-7.46-1,635.39-599.32-325.50-166.72-
Price to Book Ratio0.67-0.49-0.61-0.66-1.27-2.50-
Price-to-Total Gains Ratio-1.35-7.46-1,635.39-599.32-325.50-166.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.65
Number of shares215
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.870.08
Usd Total Gains Per Share-0.870.11
Gains per Quarter (215 shares)-186.9523.84
Gains per Year (215 shares)-747.7895.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-748-758306585
20-1496-150660130180
30-2243-225490196275
40-2991-3002121261370
50-3739-3750151326465
60-4487-4498181391560
70-5234-5246211457655
80-5982-5994241522750
90-6730-6742271587845
100-7478-7490301652940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%37.03.00.092.5%54.04.00.093.1%
Book Value Change Per Share2.02.00.050.0%6.04.02.050.0%11.06.03.055.0%27.010.03.067.5%40.013.05.069.0%
Dividend per Share0.00.04.00.0%3.00.09.025.0%9.00.011.045.0%28.00.012.070.0%38.00.020.065.5%
Total Gains per Share2.02.00.050.0%7.04.01.058.3%12.06.02.060.0%29.09.02.072.5%44.010.04.075.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Grifols SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.490-0.870-75%-0.062-98%-0.217-94%0.076-4702%0.122-2958%
Book Value Per Share--7.0219.778-28%10.830-35%9.703-28%8.539-18%5.885+19%
Current Ratio--2.6562.206+20%2.532+5%2.257+18%2.242+19%2.617+1%
Debt To Asset Ratio--0.5980.615-3%0.618-3%0.615-3%0.597+0%0.621-4%
Debt To Equity Ratio--2.1752.325-6%2.255-4%4.907-56%3.654-40%2.777-22%
Dividend Per Share----0%0.000-100%0.000-100%0.035-100%0.057-100%
Enterprise Value---6699109692.400-8888364040.414+33%-8648473017.332+29%-7516689364.476+12%-1541790712.079-77%5272633927.354-227%
Eps--0.0560.043+31%0.054+4%0.052+8%0.063-10%0.090-37%
Ev To Ebitda Ratio---4.483-5.471+22%-7.675+71%-5.565+24%-0.848-81%4.387-202%
Ev To Sales Ratio---0.764-1.128+48%-1.195+57%-1.014+33%-0.057-93%1.277-160%
Free Cash Flow Per Share--0.3030.153+98%-0.009+103%0.032+863%0.070+333%0.060+405%
Free Cash Flow To Equity Per Share--0.281-0.290+203%0.050+457%-0.135+148%0.023+1117%0.054+418%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.718----------
Intrinsic Value_10Y_min--2.949----------
Intrinsic Value_1Y_max--0.405----------
Intrinsic Value_1Y_min--0.156----------
Intrinsic Value_3Y_max--1.956----------
Intrinsic Value_3Y_min--0.592----------
Intrinsic Value_5Y_max--4.398----------
Intrinsic Value_5Y_min--1.160----------
Market Cap3926325187.200-63%6395845577.6004497687064.864+42%5585303125.168+15%5994642908.116+7%10435211518.976-39%13351391991.462-52%
Net Profit Margin--0.0350.021+64%0.025+42%0.027+29%0.052-33%0.094-63%
Operating Margin--0.1150.145-21%0.110+4%0.125-8%0.135-15%0.181-37%
Operating Ratio--0.8120.845-4%0.868-6%0.920-12%0.846-4%0.807+1%
Pb Ratio0.662-1%0.6690.489+37%0.612+9%0.660+1%1.268-47%2.497-73%
Pe Ratio20.664-1%20.88733.347-37%-4.961+124%20.457+2%21.204-1%23.314-10%
Price Per Share4.650-1%4.7004.608+2%6.615-29%6.132-23%9.197-49%10.542-55%
Price To Free Cash Flow Ratio3.833-1%3.8741.914+102%4.183-7%-10.786+378%16.083-76%20.023-81%
Price To Total Gains Ratio-1.333+1%-1.3477.457-118%1635.392-100%599.321-100%325.498-100%166.715-101%
Quick Ratio--0.9750.802+22%0.683+43%0.880+11%0.874+12%1.146-15%
Return On Assets--0.0030.002+74%0.002+69%0.002+54%0.004-22%0.009-63%
Return On Equity--0.0120.007+70%0.007+69%0.017-29%0.018-36%0.029-60%
Total Gains Per Share---3.490-0.870-75%-0.062-98%-0.216-94%0.111-3247%0.179-2050%
Usd Book Value--9553797750.0009162814957.223+4%9144666180.000+4%9096647949.908+5%8612792252.945+11%6518988485.972+47%
Usd Book Value Change Per Share---3.490-0.870-75%-0.062-98%-0.217-94%0.076-4702%0.122-2958%
Usd Book Value Per Share--7.0219.778-28%10.830-35%9.703-28%8.539-18%5.885+19%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.035-100%0.057-100%
Usd Enterprise Value---6699109692.400-8888364040.414+33%-8648473017.332+29%-7516689364.476+12%-1541790712.079-77%5272633927.354-227%
Usd Eps--0.0560.043+31%0.054+4%0.052+8%0.063-10%0.090-37%
Usd Free Cash Flow--412771260.000168339547.500+145%-7651230.000+102%28474275.000+1350%75342082.500+448%72774652.500+467%
Usd Free Cash Flow Per Share--0.3030.153+98%-0.009+103%0.032+863%0.070+333%0.060+405%
Usd Free Cash Flow To Equity Per Share--0.281-0.290+203%0.050+457%-0.135+148%0.023+1117%0.054+418%
Usd Market Cap3926325187.200-63%6395845577.6004497687064.864+42%5585303125.168+15%5994642908.116+7%10435211518.976-39%13351391991.462-52%
Usd Price Per Share4.650-1%4.7004.608+2%6.615-29%6.132-23%9.197-49%10.542-55%
Usd Profit--76554480.00043545022.500+76%45780285.000+67%49040817.500+56%79083420.750-3%121739652.375-37%
Usd Revenue--2193152430.0002001435727.500+10%1824048015.000+20%1836078195.000+19%1605304588.500+37%1410040992.000+56%
Usd Total Gains Per Share---3.490-0.870-75%-0.062-98%-0.216-94%0.111-3247%0.179-2050%
 EOD+5 -3MRQTTM+26 -11YOY+27 -123Y+24 -155Y+15 -2410Y+16 -23

3.3 Fundamental Score

Let's check the fundamental score of Grifols SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.664
Price to Book Ratio (EOD)Between0-10.662
Net Profit Margin (MRQ)Greater than00.035
Operating Margin (MRQ)Greater than00.115
Quick Ratio (MRQ)Greater than10.975
Current Ratio (MRQ)Greater than12.656
Debt to Asset Ratio (MRQ)Less than10.598
Debt to Equity Ratio (MRQ)Less than12.175
Return on Equity (MRQ)Greater than0.150.012
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.650
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Grifols SA ADR

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify " CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2025-04-23 07:15:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Grifols earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 3.5%Β means thatΒ $0.03 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Grifols SA ADR:

  • The MRQ is 3.5%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM2.1%+1.4%
TTM2.1%YOY2.5%-0.3%
TTM2.1%5Y5.2%-3.1%
5Y5.2%10Y9.4%-4.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Grifols is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 0.3% Return on Assets means thatΒ Grifols generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Grifols SA ADR:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.2%+0.1%
TTM0.2%YOY0.2%0.0%
TTM0.2%5Y0.4%-0.2%
5Y0.4%10Y0.9%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Grifols is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 1.2% Return on Equity means Grifols generated $0.01Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Grifols SA ADR:

  • The MRQ is 1.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM0.7%+0.5%
TTM0.7%YOY0.7%0.0%
TTM0.7%5Y1.8%-1.1%
5Y1.8%10Y2.9%-1.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Grifols SA ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Grifols is operatingΒ .

  • Measures how much profit Grifols makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 11.5%Β means the company generated $0.11 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Grifols SA ADR:

  • The MRQ is 11.5%. The company is operating less efficient.
  • The TTM is 14.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.5%TTM14.5%-3.0%
TTM14.5%YOY11.0%+3.5%
TTM14.5%5Y13.5%+1.0%
5Y13.5%10Y18.1%-4.6%
4.3.2.2. Operating Ratio

Measures how efficient Grifols is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.81 means that the operating costs are $0.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Grifols SA ADR:

  • The MRQ is 0.812. The company is less efficient in keeping operating costs low.
  • The TTM is 0.845. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.812TTM0.845-0.033
TTM0.845YOY0.868-0.023
TTM0.8455Y0.8460.000
5Y0.84610Y0.807+0.038
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Grifols SA ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Grifols is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.66Β means the company has $2.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Grifols SA ADR:

  • The MRQ is 2.656. The company is able to pay all its short-term debts. +1
  • The TTM is 2.206. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.656TTM2.206+0.451
TTM2.206YOY2.532-0.327
TTM2.2065Y2.242-0.036
5Y2.24210Y2.617-0.376
4.4.3.2. Quick Ratio

Measures if Grifols is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.97Β means the company can pay off $0.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Grifols SA ADR:

  • The MRQ is 0.975. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.802. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.975TTM0.802+0.173
TTM0.802YOY0.683+0.119
TTM0.8025Y0.874-0.072
5Y0.87410Y1.146-0.272
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Grifols SA ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of GrifolsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Grifols to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.60Β means that Grifols assets areΒ financed with 59.8% credit (debt) and the remaining percentage (100% - 59.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Grifols SA ADR:

  • The MRQ is 0.598. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.615. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.615-0.018
TTM0.615YOY0.618-0.003
TTM0.6155Y0.597+0.018
5Y0.59710Y0.621-0.024
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Grifols is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 217.5% means that company has $2.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Grifols SA ADR:

  • The MRQ is 2.175. The company is just not able to pay all its debts with equity.
  • The TTM is 2.325. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.175TTM2.325-0.150
TTM2.325YOY2.255+0.071
TTM2.3255Y3.654-1.329
5Y3.65410Y2.777+0.877
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Grifols generates.

  • Above 15 is considered overpriced butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of 20.89 means the investor is paying $20.89Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Grifols SA ADR:

  • The EOD is 20.664. Based on the earnings, the company is fair priced.
  • The MRQ is 20.887. Based on the earnings, the company is fair priced.
  • The TTM is 33.347. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.664MRQ20.887-0.222
MRQ20.887TTM33.347-12.460
TTM33.347YOY-4.961+38.307
TTM33.3475Y21.204+12.143
5Y21.20410Y23.314-2.110
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Grifols SA ADR:

  • The EOD is 3.833. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.874. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.914. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.833MRQ3.874-0.041
MRQ3.874TTM1.914+1.960
TTM1.914YOY4.183-2.269
TTM1.9145Y16.083-14.169
5Y16.08310Y20.023-3.940
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Grifols is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.67 means the investor is paying $0.67Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Grifols SA ADR:

  • The EOD is 0.662. Based on the equity, the company is cheap. +2
  • The MRQ is 0.669. Based on the equity, the company is cheap. +2
  • The TTM is 0.489. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.662MRQ0.669-0.007
MRQ0.669TTM0.489+0.181
TTM0.489YOY0.612-0.124
TTM0.4895Y1.268-0.779
5Y1.26810Y2.497-1.229
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets21,405,241
Total Liabilities12,798,216
Total Stockholder Equity5,883,727
 As reported
Total Liabilities 12,798,216
Total Stockholder Equity+ 5,883,727
Total Assets = 21,405,241

Assets

Total Assets21,405,241
Total Current Assets5,727,542
Long-term Assets15,677,699
Total Current Assets
Cash And Cash Equivalents 979,780
Short-term Investments 21,179
Net Receivables 1,079,316
Inventory 3,560,098
Other Current Assets 87,169
Total Current Assets  (as reported)5,727,542
Total Current Assets  (calculated)5,727,542
+/-0
Long-term Assets
Property Plant Equipment 4,310,150
Goodwill 7,403,056
Long Term Investments 528,972
Intangible Assets 2,926,132
Long-term Assets Other 167,716
Long-term Assets  (as reported)15,677,699
Long-term Assets  (calculated)15,336,026
+/- 341,673

Liabilities & Shareholders' Equity

Total Current Liabilities2,156,146
Long-term Liabilities10,642,070
Total Stockholder Equity5,883,727
Total Current Liabilities
Short-term Debt 639,661
Short Long Term Debt 523,127
Accounts payable 852,305
Other Current Liabilities 508,329
Total Current Liabilities  (as reported)2,156,146
Total Current Liabilities  (calculated)2,523,422
+/- 367,276
Long-term Liabilities
Long term Debt 8,421,113
Capital Lease Obligations 1,141,379
Long-term Liabilities Other 45,416
Long-term Liabilities  (as reported)10,642,070
Long-term Liabilities  (calculated)9,607,908
+/- 1,034,162
Total Stockholder Equity
Common Stock119,604
Retained Earnings 156,920
Accumulated Other Comprehensive Income 4,830,923
Other Stockholders Equity 776,280
Total Stockholder Equity (as reported)5,883,727
Total Stockholder Equity (calculated)5,883,727
+/-0
Other
Capital Stock119,604
Cash and Short Term Investments 1,000,959
Common Stock Shares Outstanding 1,360,818
Current Deferred Revenue70,865
Liabilities and Stockholders Equity 21,405,241
Net Debt 9,105,839
Net Invested Capital 14,827,967
Net Working Capital 3,571,396
Property Plant and Equipment Gross 6,950,825
Short Long Term Debt Total 10,085,619



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-30
> Total Assets 
0
1,888,982
1,888,982
5,344,219
5,486,724
5,807,718
5,543,025
5,912,417
5,837,321
5,627,474
5,784,323
5,846,159
5,711,151
5,841,036
7,192,367
7,276,096
8,102,746
8,449,749
9,375,155
9,095,358
9,178,563
9,601,715
9,239,045
9,539,658
9,567,865
10,129,772
11,708,358
11,116,979
11,009,939
10,920,264
10,875,229
11,433,619
11,779,675
12,477,046
13,387,065
13,323,775
14,036,984
15,542,611
15,896,382
15,597,511
15,646,913
15,274,776
16,137,599
16,213,049
19,233,835
0
19,233,835
21,039,074
21,533,977
21,350,830
21,350,830
21,432,744
22,064,498
21,454,670
21,953,010
22,291,454
20,283,644
21,405,241
21,405,24120,283,64422,291,45421,953,01021,454,67022,064,49821,432,74421,350,83021,350,83021,533,97721,039,07419,233,835019,233,83516,213,04916,137,59915,274,77615,646,91315,597,51115,896,38215,542,61114,036,98413,323,77513,387,06512,477,04611,779,67511,433,61910,875,22910,920,26411,009,93911,116,97911,708,35810,129,7729,567,8659,539,6589,239,0459,601,7159,178,5639,095,3589,375,1558,449,7498,102,7467,276,0967,192,3675,841,0365,711,1515,846,1595,784,3235,627,4745,837,3215,912,4175,543,0255,807,7185,486,7245,344,2191,888,9821,888,9820
   > Total Current Assets 
0
1,144,082
1,144,082
2,109,666
1,679,898
1,929,215
1,772,920
1,896,772
1,921,424
1,934,564
1,940,745
2,039,313
1,982,701
2,139,660
2,416,613
2,412,406
2,707,671
2,913,122
2,824,727
2,751,887
2,841,230
3,089,472
2,953,273
2,920,719
2,953,073
3,122,514
2,952,170
2,851,032
2,915,714
2,945,316
2,965,872
2,947,373
3,024,376
3,483,251
3,488,966
3,424,363
3,659,798
5,362,184
3,663,767
3,554,170
3,643,616
3,164,954
3,085,574
3,239,500
5,510,280
5,510,280
2,685,161
4,432,773
4,653,587
4,708,888
4,708,888
4,804,772
5,015,368
6,451,905
6,759,091
6,914,895
5,323,263
5,727,542
5,727,5425,323,2636,914,8956,759,0916,451,9055,015,3684,804,7724,708,8884,708,8884,653,5874,432,7732,685,1615,510,2805,510,2803,239,5003,085,5743,164,9543,643,6163,554,1703,663,7675,362,1843,659,7983,424,3633,488,9663,483,2513,024,3762,947,3732,965,8722,945,3162,915,7142,851,0322,952,1703,122,5142,953,0732,920,7192,953,2733,089,4722,841,2302,751,8872,824,7272,913,1222,707,6712,412,4062,416,6132,139,6601,982,7012,039,3131,940,7451,934,5641,921,4241,896,7721,772,9201,929,2151,679,8982,109,6661,144,0821,144,0820
       Cash And Cash Equivalents 
0
239,649
239,649
583,792
162,615
340,586
164,968
314,640
400,600
473,327
404,988
479,157
488,277
708,777
684,597
736,904
917,704
1,079,146
797,775
788,734
891,848
1,142,500
1,007,577
807,019
900,461
895,009
737,291
750,218
815,115
886,521
846,522
668,499
582,008
1,033,792
576,712
553,697
792,134
741,982
637,697
878,406
1,033,195
579,647
380,980
397,864
655,493
0
-2,685,161
525,094
547,979
425,655
425,655
523,352
484,226
529,577
448,545
2,113,221
644,942
979,780
979,780644,9422,113,221448,545529,577484,226523,352425,655425,655547,979525,094-2,685,1610655,493397,864380,980579,6471,033,195878,406637,697741,982792,134553,697576,7121,033,792582,008668,499846,522886,521815,115750,218737,291895,009900,461807,0191,007,5771,142,500891,848788,734797,7751,079,146917,704736,904684,597708,777488,277479,157404,988473,327400,600314,640164,968340,586162,615583,792239,649239,6490
       Short-term Investments 
0
12,946
12,946
19,254
24,543
16,904
29,167
26,943
795
0
482
757
527
0
493
350
368
0
690
1,177
779
0
965
1,983
1,779
957
12,541
868
11,381
525
10,513
21,059
51,392
822
178,232
169,434
2,764
1,727,429
13,035
12,317
12,288
10,861
6,077
9,681
2,026,430
0
5,370,322
36,058
30,986
30,627
30,627
33,883
59,410
116,143
160,379
146,329
161,799
21,179
21,179161,799146,329160,379116,14359,41033,88330,62730,62730,98636,0585,370,32202,026,4309,6816,07710,86112,28812,31713,0351,727,4292,764169,434178,23282251,39221,05910,51352511,38186812,5419571,7791,98396507791,17769003683504930527757482079526,94329,16716,90424,54319,25412,94612,9460
       Net Receivables 
0
282,994
282,994
495,450
482,080
522,299
556,479
506,722
479,529
441,788
517,776
553,504
489,891
462,655
689,852
624,488
623,536
608,328
623,945
594,071
552,286
477,803
468,114
554,882
475,214
528,518
485,251
478,038
471,385
385,265
404,251
415,744
462,839
401,573
596,716
458,962
464,280
470,495
507,617
534,973
568,294
504,200
495,777
644,698
434,136
495,476
434,136
772,978
754,820
884,234
884,234
721,208
908,030
810,860
998,015
935,083
1,007,363
1,079,316
1,079,3161,007,363935,083998,015810,860908,030721,208884,234884,234754,820772,978434,136495,476434,136644,698495,777504,200568,294534,973507,617470,495464,280458,962596,716401,573462,839415,744404,251385,265471,385478,038485,251528,518475,214554,882468,114477,803552,286594,071623,945608,328623,536624,488689,852462,655489,891553,504517,776441,788479,529506,722556,479522,299482,080495,450282,994282,9940
       Other Current Assets 
0
80,628
80,628
13,344
13,636
19,085
26,128
15,514
15,708
20,805
15,270
16,420
19,256
21,315
20,586
19,592
22,487
23,669
31,765
26,367
37,613
31,091
31,258
27,951
32,896
48,324
44,022
174,719
34,999
32,354
40,921
55,937
63,942
42,344
21,625
205,212
73,450
58,111
45,925
44,293
43,763
51,750
64,734
70,864
131,629
70,289
131,629
177,065
118,445
121,946
121,946
225,017
136,429
1,652,191
1,504,798
260,235
53,550
87,169
87,16953,550260,2351,504,7981,652,191136,429225,017121,946121,946118,445177,065131,62970,289131,62970,86464,73451,75043,76344,29345,92558,11173,450205,21221,62542,34463,94255,93740,92132,35434,999174,71944,02248,32432,89627,95131,25831,09137,61326,36731,76523,66922,48719,59220,58621,31519,25616,42015,27020,80515,70815,51426,12819,08513,63613,34480,62880,6280
   > Long-term Assets 
0
744,900
744,900
3,234,553
3,806,826
3,878,503
3,770,105
4,015,645
3,915,897
3,692,910
3,843,578
3,806,846
3,728,450
3,701,376
4,775,754
4,863,690
5,395,075
5,536,627
6,550,428
6,343,471
6,337,333
6,512,243
6,285,772
6,618,939
6,614,792
7,007,258
8,756,188
8,265,947
8,094,225
7,974,948
7,909,357
8,486,246
8,755,299
8,993,795
9,898,099
9,899,412
10,377,186
10,180,427
12,232,615
12,043,341
12,003,297
12,109,822
13,052,025
12,973,549
13,723,555
0
-2,685,161
16,606,301
14,949,982
16,641,942
16,641,942
16,627,972
17,049,130
15,002,765
15,193,919
15,376,559
14,960,381
15,677,699
15,677,69914,960,38115,376,55915,193,91915,002,76517,049,13016,627,97216,641,94216,641,94214,949,98216,606,301-2,685,161013,723,55512,973,54913,052,02512,109,82212,003,29712,043,34112,232,61510,180,42710,377,1869,899,4129,898,0998,993,7958,755,2998,486,2467,909,3577,974,9488,094,2258,265,9478,756,1887,007,2586,614,7926,618,9396,285,7726,512,2436,337,3336,343,4716,550,4285,536,6275,395,0754,863,6904,775,7543,701,3763,728,4503,806,8463,843,5783,692,9103,915,8974,015,6453,770,1053,878,5033,806,8263,234,553744,900744,9000
       Property Plant Equipment 
0
434,131
434,131
639,735
868,331
775,869
772,513
823,251
809,060
810,107
835,705
840,880
826,604
840,238
942,446
999,201
1,077,813
1,147,782
1,575,917
1,559,928
1,582,389
1,644,402
1,606,963
1,659,780
1,680,447
1,809,852
1,841,190
1,775,907
1,740,630
1,760,053
1,728,516
1,819,289
1,868,809
1,951,983
1,995,589
2,680,255
2,112,661
2,863,403
2,209,941
2,911,500
2,173,983
3,002,803
2,423,071
3,135,099
3,343,154
3,343,154
3,343,154
4,227,930
4,168,489
3,220,428
3,220,428
3,225,684
3,278,650
4,192,363
3,249,983
4,214,569
3,162,439
4,310,150
4,310,1503,162,4394,214,5693,249,9834,192,3633,278,6503,225,6843,220,4283,220,4284,168,4894,227,9303,343,1543,343,1543,343,1543,135,0992,423,0713,002,8032,173,9832,911,5002,209,9412,863,4032,112,6612,680,2551,995,5891,951,9831,868,8091,819,2891,728,5161,760,0531,740,6301,775,9071,841,1901,809,8521,680,4471,659,7801,606,9631,644,4021,582,3891,559,9281,575,9171,147,7821,077,813999,201942,446840,238826,604840,880835,705810,107809,060823,251772,513775,869868,331639,735434,131434,1310
       Goodwill 
0
189,448
189,448
0
0
1,895,101
1,836,684
1,950,389
1,905,820
1,869,899
1,925,703
1,937,064
1,879,973
1,829,141
2,748,241
2,779,267
3,089,570
3,174,732
3,574,483
3,440,974
3,434,748
3,532,359
3,381,398
3,464,745
3,446,734
3,643,995
3,643,995
5,023,903
0
4,590,498
4,590,498
4,993,142
0
5,209,230
5,209,230
5,416,606
0
5,507,063
5,507,063
5,501,972
0
5,332,271
5,332,271
5,988,765
6,228,901
0
6,228,901
7,847,911
7,011,909
7,011,909
7,011,909
6,898,821
0
6,802,127
6,802,127
7,101,997
0
7,403,056
7,403,05607,101,9976,802,1276,802,12706,898,8217,011,9097,011,9097,011,9097,847,9116,228,90106,228,9015,988,7655,332,2715,332,27105,501,9725,507,0635,507,06305,416,6065,209,2305,209,23004,993,1424,590,4984,590,49805,023,9033,643,9953,643,9953,446,7343,464,7453,381,3983,532,3593,434,7483,440,9743,574,4833,174,7323,089,5702,779,2672,748,2411,829,1411,879,9731,937,0641,925,7031,869,8991,905,8201,950,3891,836,6841,895,10100189,448189,4480
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232,421
307,941
268,879
295,103
193,750
330,171
228,262
173,862
228,820
366,980
267,653
264,308
143,984
2,089,839
2,071,069
2,039,351
2,067,177
2,129,789
2,136,964
0
0
0
2,554,608
0
2,443,078
0
2,536,044
2,597,295
565,105
0
559,998
690,097
528,972
528,972690,097559,9980565,1052,597,2952,536,04402,443,07802,554,6080002,136,9642,129,7892,067,1772,039,3512,071,0692,089,839143,984264,308267,653366,980228,820173,862228,262330,171193,750295,103268,879307,941232,4210000000000000000000000000
       Intangible Assets 
0
78,299
78,299
0
0
1,008,307
971,901
1,038,977
1,000,746
969,095
989,745
974,645
949,631
946,435
982,524
984,153
1,048,567
1,068,361
1,193,813
1,149,060
1,138,643
1,161,572
1,107,712
1,139,126
1,130,970
1,195,302
6,529,475
1,101,789
5,972,107
1,269,342
5,789,588
1,342,527
6,580,700
1,385,537
7,414,608
1,417,377
7,880,443
1,433,534
7,801,290
1,433,768
7,663,567
1,557,650
8,357,163
1,570,576
1,003,710
0
1,003,710
1,736,913
1,326,506
10,646,785
10,646,785
2,880,245
10,876,233
2,832,196
10,741,139
2,880,924
0
2,926,132
2,926,13202,880,92410,741,1392,832,19610,876,2332,880,24510,646,78510,646,7851,326,5061,736,9131,003,71001,003,7101,570,5768,357,1631,557,6507,663,5671,433,7687,801,2901,433,5347,880,4431,417,3777,414,6081,385,5376,580,7001,342,5275,789,5881,269,3425,972,1071,101,7896,529,4751,195,3021,130,9701,139,1261,107,7121,161,5721,138,6431,149,0601,193,8131,068,3611,048,567984,153982,524946,435949,631974,645989,745969,0951,000,7461,038,977971,9011,008,3070078,29978,2990
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
196,308
77,582
95,469
86,385
245,559
61,082
103,026
49,049
505,430
152,044
224,468
119,774
564,251
131,545
254,449
126,396
812,555
142,002
232,391
882,614
882,614
15,840
344,972
1,930,408
197,837
0
0
0
0
0
0
0
0
00000000197,8371,930,408344,97215,840882,614882,614232,391142,002812,555126,396254,449131,545564,251119,774224,468152,044505,43049,049103,02661,082245,55986,38595,46977,582196,3080000000000000000000000000
> Total Liabilities 
0
1,181,592
1,181,592
3,830,625
3,888,114
4,142,724
3,858,297
4,074,583
3,983,199
3,746,733
3,826,135
3,901,399
3,741,961
3,733,832
4,967,995
5,038,472
5,563,079
5,786,861
6,239,855
6,021,473
5,975,546
6,300,325
5,941,610
6,127,307
6,035,427
6,401,794
7,891,593
7,532,149
7,421,824
7,286,299
7,165,384
7,462,375
7,632,305
7,780,442
8,510,000
8,437,956
8,745,110
8,696,843
8,689,846
8,556,735
8,538,992
8,554,721
8,940,868
9,275,958
11,916,737
0
11,916,737
12,619,686
13,076,433
13,175,625
13,175,625
13,209,179
13,495,808
13,468,378
13,831,216
13,996,180
12,288,584
12,798,216
12,798,21612,288,58413,996,18013,831,21613,468,37813,495,80813,209,17913,175,62513,175,62513,076,43312,619,68611,916,737011,916,7379,275,9588,940,8688,554,7218,538,9928,556,7358,689,8468,696,8438,745,1108,437,9568,510,0007,780,4427,632,3057,462,3757,165,3847,286,2997,421,8247,532,1497,891,5936,401,7946,035,4276,127,3075,941,6106,300,3255,975,5466,021,4736,239,8555,786,8615,563,0795,038,4724,967,9953,733,8323,741,9613,901,3993,826,1353,746,7333,983,1994,074,5833,858,2974,142,7243,888,1143,830,6251,181,5921,181,5920
   > Total Current Liabilities 
0
423,126
423,126
962,930
555,483
646,077
660,812
677,890
641,208
592,865
611,595
742,411
656,592
715,296
743,392
796,993
985,538
1,079,711
1,000,248
1,005,317
975,446
1,053,006
893,200
975,191
925,678
1,071,763
944,838
900,321
952,067
977,987
948,036
1,015,690
1,086,420
1,257,321
1,215,110
1,276,459
1,394,814
1,366,558
1,333,835
1,240,627
1,244,510
1,335,138
1,560,858
1,921,478
3,474,312
3,474,312
3,474,312
1,656,330
1,955,847
2,041,284
2,041,284
1,876,984
2,025,059
2,315,604
3,038,364
4,111,962
2,355,575
2,156,146
2,156,1462,355,5754,111,9623,038,3642,315,6042,025,0591,876,9842,041,2842,041,2841,955,8471,656,3303,474,3123,474,3123,474,3121,921,4781,560,8581,335,1381,244,5101,240,6271,333,8351,366,5581,394,8141,276,4591,215,1101,257,3211,086,4201,015,690948,036977,987952,067900,321944,8381,071,763925,678975,191893,2001,053,006975,4461,005,3171,000,2481,079,711985,538796,993743,392715,296656,592742,411611,595592,865641,208677,890660,812646,077555,483962,930423,126423,1260
       Short-term Debt 
0
191,635
194,915
509,726
121,650
150,224
184,689
208,115
184,444
192,003
187,829
234,971
225,085
251,389
154,638
175,853
175,730
165,860
177,826
188,772
212,602
186,797
196,813
191,939
204,761
203,944
158,813
129,333
170,557
133,067
174,405
192,648
247,568
268,199
329,969
325,269
415,426
320,802
331,406
260,059
319,916
319,571
637,112
899,517
2,398,341
0
2,398,341
402,456
0
761,319
761,319
732,170
757,246
897,915
1,745,272
2,752,615
0
639,661
639,66102,752,6151,745,272897,915757,246732,170761,319761,3190402,4562,398,34102,398,341899,517637,112319,571319,916260,059331,406320,802415,426325,269329,969268,199247,568192,648174,405133,067170,557129,333158,813203,944204,761191,939196,813186,797212,602188,772177,826165,860175,730175,853154,638251,389225,085234,971187,829192,003184,444208,115184,689150,224121,650509,726194,915191,6350
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,905,583
6,491,862
6,148,992
170,557
96,569
174,405
188,757
180,469
257,772
414,895
289,133
415,426
276,397
0
215,445
0
276,929
0
854,202
0
0
0
338,987
0
578,917
0
0
0
790,814
0
2,568,853
0
523,127
523,12702,568,8530790,814000578,9170338,987000854,2020276,9290215,4450276,397415,426289,133414,895257,772180,469188,757174,40596,569170,5576,148,9926,491,8624,905,5830000000000000000000000000
       Accounts payable 
0
160,678
160,678
292,011
0
280,722
302,285
277,635
268,966
228,405
219,377
241,198
241,825
273,621
369,300
370,755
393,078
439,631
381,341
367,794
351,816
409,986
379,996
400,542
390,979
461,073
461,073
394,821
0
423,096
423,096
427,194
0
561,883
561,883
536,743
0
581,882
581,882
551,905
0
601,618
601,618
580,247
628,992
628,992
628,992
701,158
731,918
731,918
731,918
708,970
0
813,114
813,114
877,723
0
852,305
852,3050877,723813,114813,1140708,970731,918731,918731,918701,158628,992628,992628,992580,247601,618601,6180551,905581,882581,8820536,743561,883561,8830427,194423,096423,0960394,821461,073461,073390,979400,542379,996409,986351,816367,794381,341439,631393,078370,755369,300273,621241,825241,198219,377228,405268,966277,635302,285280,7220292,011160,678160,6780
       Other Current Liabilities 
0
18,236
63,361
133,966
433,833
210,440
163,305
160,370
140,180
6,243
161,509
176,536
4,873
182,823
-93,259
199,968
-166,735
453,847
-271,026
41,211
135,235
447,032
65,776
350,009
-76,871
399,742
786,025
-101,179
781,510
407,595
773,631
-114,050
838,852
411,714
885,141
-121,390
979,388
453,236
1,002,429
-63,136
924,594
389,969
923,746
353,109
446,979
123,594
446,979
476,114
1,223,929
1,279,965
1,279,965
406,914
1,267,813
565,382
1,293,092
430,611
2,355,575
508,329
508,3292,355,575430,6111,293,092565,3821,267,813406,9141,279,9651,279,9651,223,929476,114446,979123,594446,979353,109923,746389,969924,594-63,1361,002,429453,236979,388-121,390885,141411,714838,852-114,050773,631407,595781,510-101,179786,025399,742-76,871350,00965,776447,032135,23541,211-271,026453,847-166,735199,968-93,259182,8234,873176,536161,5096,243140,180160,370163,305210,440433,833133,96663,36118,2360
   > Long-term Liabilities 
0
758,466
758,466
2,867,695
3,332,631
3,496,647
3,197,485
3,396,693
3,341,991
3,153,868
3,214,540
3,158,988
3,085,369
3,018,536
4,224,603
4,241,479
4,577,541
4,707,150
5,239,607
5,016,156
5,000,100
5,247,319
5,048,410
5,152,116
5,109,749
5,330,031
6,946,755
6,631,828
6,469,757
6,308,312
6,217,348
6,446,685
6,545,885
6,523,121
7,294,890
7,161,497
7,350,296
7,330,285
7,356,011
7,316,108
7,294,482
7,219,583
7,380,010
7,354,480
8,442,425
0
8,442,425
10,963,356
8,154,264
11,134,341
11,134,341
11,332,195
11,470,749
11,152,774
10,792,852
9,884,218
9,933,009
10,642,070
10,642,0709,933,0099,884,21810,792,85211,152,77411,470,74911,332,19511,134,34111,134,3418,154,26410,963,3568,442,42508,442,4257,354,4807,380,0107,219,5837,294,4827,316,1087,356,0117,330,2857,350,2967,161,4977,294,8906,523,1216,545,8856,446,6856,217,3486,308,3126,469,7576,631,8286,946,7555,330,0315,109,7495,152,1165,048,4105,247,3195,000,1005,016,1565,239,6074,707,1504,577,5414,241,4794,224,6033,018,5363,085,3693,158,9883,214,5403,153,8683,341,9913,396,6933,197,4853,496,6473,332,6312,867,695758,466758,4660
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
648,935
613,706
612,169
580,302
321,692
389,914
490,800
313,476
502,613
541,589
499,437
446,719
544,198
492,373
533,082
566,296
627,755
649,057
648,372
682,364
682,364
0
1,808,355
2,051,734
2,051,734
0
0
0
0
0
0
0
0
000000002,051,7342,051,7341,808,3550682,364682,364648,372649,057627,755566,296533,082492,373544,198446,719499,437541,589502,613313,476490,800389,914321,692580,302612,169613,706648,9350000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,620
0
0
0
173,768
0
0
0
287,205
0
0
0
331,808
0
0
0
575,515
0
0
633,240
633,240
0
0
1,622,641
1,622,641
0
0
0
0
0
0
0
0
000000001,622,6411,622,64100633,240633,24000575,515000331,808000287,205000173,76800070,6200000000000000000000000000
> Total Stockholder Equity
0
693,040
693,040
1,500,653
1,596,238
1,662,507
1,682,267
1,831,277
1,849,945
1,876,768
1,955,489
1,936,921
1,962,506
2,101,262
2,219,681
2,231,612
2,534,163
2,658,123
3,131,093
3,070,151
3,198,391
3,296,203
3,292,597
3,408,203
3,528,399
3,721,481
3,810,432
3,579,042
3,582,689
3,629,079
3,705,408
3,967,400
4,145,026
4,225,554
4,401,149
4,393,764
4,771,872
4,822,119
5,543,509
5,364,941
5,347,090
5,108,392
5,423,090
5,168,166
5,523,609
0
7,317,098
6,329,834
376,915
5,852,832
5,852,832
5,861,818
6,127,078
5,827,166
5,943,740
5,592,707
5,349,895
5,883,727
5,883,7275,349,8955,592,7075,943,7405,827,1666,127,0785,861,8185,852,8325,852,832376,9156,329,8347,317,09805,523,6095,168,1665,423,0905,108,3925,347,0905,364,9415,543,5094,822,1194,771,8724,393,7644,401,1494,225,5544,145,0263,967,4003,705,4083,629,0793,582,6893,579,0423,810,4323,721,4813,528,3993,408,2033,292,5973,296,2033,198,3913,070,1513,131,0932,658,1232,534,1632,231,6122,219,6812,101,2621,962,5061,936,9211,955,4891,876,7681,849,9451,831,2771,682,2671,662,5071,596,2381,500,653693,040693,0400
   Common Stock
0
0
106,532
114,914
114,914
117,882
117,882
117,882
117,882
1,008,237
1,009,870
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
119,604
119,604
1,030,332
119,604
119,604
119,604
1,030,332
119,604
119,604
119,604
119,604
119,604
119,604
119,604119,604119,604119,604119,604119,6041,030,332119,604119,604119,6041,030,332119,604119,604119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,332119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,009,8701,008,237117,882117,882117,882117,882114,914114,914106,53200
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
352,871
352,871
-91,640
549,103
627,074
-10,136
72,410
27,231
614,905
943,526
881,453
822,801
794,134
1,137,131
1,020,805
1,226,174
1,312,734
2,127,467
1,836,889
1,825,025
1,911,916
2,313,528
2,175,453
2,160,681
2,337,311
2,837,725
2,333,271
2,183,016
2,121,455
2,710,096
2,673,530
2,701,838
2,790,768
3,448,635
3,126,202
3,367,722
3,353,053
4,512,732
4,296,960
4,011,637
3,503,248
4,330,055
4,035,208
4,409,462
0
5,523,609
5,314,614
0
4,984,720
5,092,986
5,046,399
5,252,116
4,949,582
5,044,737
4,671,403
4,376,898
4,830,923
4,830,9234,376,8984,671,4035,044,7374,949,5825,252,1165,046,3995,092,9864,984,72005,314,6145,523,60904,409,4624,035,2084,330,0553,503,2484,011,6374,296,9604,512,7323,353,0533,367,7223,126,2023,448,6352,790,7682,701,8382,673,5302,710,0962,121,4552,183,0162,333,2712,837,7252,337,3112,160,6812,175,4532,313,5281,911,9161,825,0251,836,8892,127,4671,312,7341,226,1741,020,8051,137,131794,134822,801881,453943,526614,90527,23172,410-10,136627,074549,103-91,640352,871352,8710
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
224,656
118,124
938,322
888,428
1,612,200
888,426
937,642
888,426
-3,060
801,446
1,669,026
821,819
0
910,728
934,006
849,400
-69,252
841,476
852,153
918,286
-58,575
853,834
848,703
842,018
-68,710
842,018
848,306
848,306
-62,422
855,287
855,287
855,287
-55,441
855,287
861,078
861,144
-49,584
861,621
866,958
866,994
-43,734
843,496
746,539
746,539
4,988,419
1,793,489
751,967
-376,915
856,774
748,508
752,036
752,036
757,980
757,980
765,441
765,441
776,280
776,280765,441765,441757,980757,980752,036752,036748,508856,774-376,915751,9671,793,4894,988,419746,539746,539843,496-43,734866,994866,958861,621-49,584861,144861,078855,287-55,441855,287855,287855,287-62,422848,306848,306842,018-68,710842,018848,703853,834-58,575918,286852,153841,476-69,252849,400934,006910,7280821,8191,669,026801,446-3,060888,426937,642888,4261,612,200888,428938,322118,124224,6560



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,212,382
Cost of Revenue-4,417,844
Gross Profit2,794,5382,794,538
 
Operating Income (+$)
Gross Profit2,794,538
Operating Expense-1,602,523
Operating Income1,192,0151,192,015
 
Operating Expense (+$)
Research Development384,036
Selling General Administrative1,255,291
Selling And Marketing Expenses-
Operating Expense1,602,5231,639,327
 
Net Interest Income (+$)
Interest Income44,423
Interest Expense-602,571
Other Finance Cost-142,976
Net Interest Income-701,124
 
Pretax Income (+$)
Operating Income1,192,015
Net Interest Income-701,124
Other Non-Operating Income Expenses-
Income Before Tax (EBT)443,9961,940,034
EBIT - interestExpense = 443,996
388,110
759,491
Interest Expense602,571
Earnings Before Interest and Taxes (EBIT)1,046,5671,046,567
Earnings Before Interest and Taxes (EBITDA)1,484,464
 
After tax Income (+$)
Income Before Tax443,996
Tax Provision-231,190
Net Income From Continuing Ops212,806212,806
Net Income156,920
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses6,020,367
Total Other Income/Expenses Net-748,019701,124
 

Technical Analysis of Grifols
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Grifols. The general trend of Grifols is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Grifols's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Grifols Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Grifols SA ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.8 < 4.8 < 4.8.

The bearish price targets are: 4.23 > 4.202 > 3.762.

Know someone who trades $GIKLY? Share this with them.πŸ‘‡

Grifols SA ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Grifols SA ADR. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Grifols SA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Grifols SA ADR.

Grifols SA ADR Daily Moving Average Convergence/Divergence (MACD) ChartGrifols SA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Grifols SA ADR. The current adx is .

Grifols SA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Grifols SA ADR.

Grifols SA ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Grifols SA ADR.

Grifols SA ADR Daily Relative Strength Index (RSI) ChartGrifols SA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Grifols SA ADR.

Grifols SA ADR Daily Stochastic Oscillator ChartGrifols SA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Grifols SA ADR.

Grifols SA ADR Daily Commodity Channel Index (CCI) ChartGrifols SA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Grifols SA ADR.

Grifols SA ADR Daily Chande Momentum Oscillator (CMO) ChartGrifols SA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Grifols SA ADR.

Grifols SA ADR Daily Williams %R ChartGrifols SA ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Grifols SA ADR.

Grifols SA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Grifols SA ADR.

Grifols SA ADR Daily Average True Range (ATR) ChartGrifols SA ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Grifols SA ADR.

Grifols SA ADR Daily On-Balance Volume (OBV) ChartGrifols SA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Grifols SA ADR.

Grifols SA ADR Daily Money Flow Index (MFI) ChartGrifols SA ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Grifols SA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Grifols SA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.650
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Grifols with someone you think should read this too:
  • Are you bullish or bearish on Grifols? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Grifols? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Grifols SA ADR.

Receive notifications about Grifols SA ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.